LBH589

panobinostat

Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for LBH589, covering 2010-04-08 to 2021-08-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma [Phase 2]